Korea hypertension fact sheet 2018

Jin Won Jeong, Gilja Shin, Dong Soo Kim, Gheun Ho Kim, Seok Min Kang, Wook Bum Pyun, Hae Young Lee, Wook Jin Chung, Sang Hyun Ihm, Kwang Il Kim, Eun Joo Cho, Il Suk Sohn, Sungha Park, Jinho Shin, Ki Chul Sung, Sung Kee Ryu, Jidong Sung, Dae Jung Kim, Dong Ryeol Ryu, Dong Heon YangByung Su Yoo, Moo Yong Rhee, Seung Hoon Lee, Eun Mi Lee, Joong Hwa Chung, Jin Ok Jeong, Jin Han, Young Mi Hong, Jin Yong Hwang, Chang Gyu Park, Se Joong Rim, Song Vogue Ahn, Sun Ha Jee, Min Ho Shin, Jong Ku Park, Il Suh, Tae Yong Lee, Seung Won Lee, Hyeon Chang Kim, Myeong Chan Cho

Research output: Contribution to journalArticlepeer-review

75 Scopus citations


Background: The Korea Hypertension Fact Sheet 2018 aims to overview the magnitude and management status of hypertension, and their trends in Korea. Methods: The Hypertension Epidemiology Research Group analyzed the 1998-2016 Korea National Health and Nutrition Examination Survey data and the 2002-2016 Korea National Health Insurance Big Data. Results: The population average of systolic/diastolic blood pressure was 118/77 mmHg among Korean adults (age 30+) in 2016, showing little change in recent 10 years. However, the number of people with hypertension increased steadily, exceeding 11 million. The number of people diagnosed with hypertension increased from 3 million in 2002 to 8.9 million in 2016. The number of people using antihypertensive medication increased from 2.5 million in 2002 to 8.2 million in 2016. However, only 5.7 million people are being treated constantly. Hypertension awareness, treatment, and control rates increased fast until 2007, but showed a plateau thereafter. More than half of the young hypertensive patients (30-49 years) did not know about and treat for their hypertension. Among patients prescribed antihypertensive medications, 45% was elderly people over the age of 65 years, 57% used anti-diabetic or cholesterol-lowering medications, and 60% were prescribed two or more class of antihypertensive medications simultaneously. Conclusions: In Korea, the level of hypertension management has considerably improved over the last 20 years. In order to achieve further improvement in hypertension management status, we need to find the vulnerable subgroups and develop subgroup-specific intervention strategies. It is also becoming more important to manage hypertensive patients at older age and those with concurrent chronic diseases.

Original languageEnglish
Article number13
JournalClinical Hypertension
Issue number1
StatePublished - 1 Oct 2018

Bibliographical note

Publisher Copyright:
© 2018 The Author(s).


  • Anti-hypertensive medication
  • Awareness
  • Control
  • Hypertension
  • Korea
  • Prevalence
  • Treatment


Dive into the research topics of 'Korea hypertension fact sheet 2018'. Together they form a unique fingerprint.

Cite this